Brukinsa 80 mg Capsule

Brukinsa 80 mg Capsule should be taken exactly as prescribed by your doctor, with or without food. Try to take it at the same time each day to maintain consistent levels in the body. If a dose is missed, it should be taken as soon as possible on the same day, and the regular schedule should be resumed the next day.

Common side effects of Brukinsa 80 mg Capsule include decreased blood cell counts such as neutrophils and platelets, upper respiratory tract infections, and musculoskeletal pain. These effects may occur due to its action on blood cells and immune function. Regular monitoring may be required during treatment.

Brukinsa 80 mg Capsule should be used with caution. It may increase the risk of bleeding, infections, and low blood cell counts, so regular monitoring is required during treatment. It may also increase the risk of heart rhythm problems and liver-related effects. The liver function should be monitored. There is a risk of developing other malignancies, including skin cancers, so appropriate precautions such as sun protection may be advised. This medicine can cause harm to an unborn baby. Therefore, it should not be used during pregnancy, and effective contraception is recommended. Inform your doctor about all medicines you are taking. Interactions may occur with other medicines.

• Treatment of Mantle-cell lymphoma
• Waldenström's Macroglobulinemia
• Marginal Zone Lymphoma
• Small Lymphocytic Lymphoma
• Follicular lymphoma

• During treatment with Brukinsa 80 mg Capsule, your doctor may advise regular blood tests to monitor blood cell counts. This helps detect early changes such as low neutrophils or platelets, allowing timely management and reducing the risk of complications during treatment.
• Be alert for signs of infection, such as fever, cough, or unusual fatigue. This medicine may increase the risk of infections, including serious ones. Early reporting of symptoms can help in prompt treatment and prevent worsening of the condition.
• Watch for any unusual bleeding or bruising, such as nosebleeds, blood in urine, or prolonged bleeding from cuts. Brukinsa 80 mg Capsule may increase the risk of bleeding. Immediate medical attention may be required if such symptoms occur.
• Inform your doctor before any planned surgery or dental procedure. This medicine may increase the risk of bleeding. Temporary interruption of treatment may be required depending on the procedure and clinical condition.
• Monitor for symptoms such as palpitations, dizziness, or shortness of breath. This medicine may be associated with heart rhythm problems. Prompt reporting of such symptoms allows early evaluation and management.
• Use effective contraception during treatment and avoid pregnancy. This medicine may cause harm to the unborn baby. Discuss appropriate contraceptive methods with your doctor before starting treatment.
• Limit sun exposure and use protective measures such as sunscreen and protective clothing. There may be an increased risk of developing skin-related malignancies during treatment.
• Inform your doctor about all medications, including herbal products, before starting this medicine. Certain medicines can affect how this drug works, especially those that influence liver enzymes involved in drug metabolism.